Skip to main content
3 Wissenschaftler
© Universitätsklinikum Bonn / Alessandro Winkler

News categories: Publication

Immune cells remember their location

A new AI-based method reconstructs spatial information about where immune cells were originally located in an organ, even after these cells have been removed from the tissue and analyzed individually. To accomplish this, Researchers at the University Hospital Bonn (UKB) and the University of Bonn use the transcriptome, i.e., the entirety of all messenger RNA transcripts produced by genes within a cell at a given time. The work has now been published in the journal Advanced Science and introduces the new MERLIN algorithm.

How do immune cells change and contribute to diseases in organs? Single-cell RNA sequencing technology has revolutionized immunological research, by revealing which genes are active in individual immune cells. "However, when cells are isolated, information about which part of an organ the cells originated from is inevitably lost. In highly structured organs such as the kidney or brain, this spatial information is crucial for understanding health and disease," says Prof. Christian Kurts, Director of the Institute for Molecular Medicine and Experimental Immunology at the UKB. He is a member of the ImmunoSensation³ Cluster of Excellence and the Transdisciplinary Research Area (TRA) "Life & Health" at the University of Bonn.

MERLIN makes the memory of immune cells accessible

"We discovered that macrophages carry a molecular memory of their local environment," explains Junping Yin, first author of the study. "Even after isolation, their gene activity still reflects which area of the kidney or brain they originate from. MERLIN makes this information accessible again."

MERLIN was developed at the intersection of immunology, nephrology, and bioinformatics. The algorithm uses machine learning to recognize characteristic patterns in gene activity that are influenced by local tissue conditions such as oxygen deficiency or salt concentration.

"From a bioinformatics perspective, it was crucial that MERLIN be trained on multiple independent datasets," says Jian Li, senior author and bioinformatician. "This allows the system to learn real biological signals. It can then be applied to completely new or previously published datasets."

The researchers were able to show that MERLIN not only works in mouse models, but also correctly predicts the spatial origin of macrophages – large specialized white blood cells – in human kidney samples. In addition, the approach was transferred to the brain, where the positions of microglia, the brain's immune cells, were successfully reconstructed.

MERLIN provides new insights into kidney disease

The application to kidney disease is particularly relevant. By analyzing previously published data sets on inflammation, sepsis, ischemia-reperfusion injury occurring after transplantation, and diabetic nephropathy, MERLIN confirmed known disease mechanisms and provided new insights into region-specific immune responses and therapeutic effects. "This is a major advance for nephrology," emphasizes senior author Christian Kurts. "We see that immune responses and drug effects depend heavily on the specific region of the kidney, as we know from patient care."

The study was conducted at the UKB in the context of the ImmunoSensation³ Cluster of Excellence and TRA “Life & Health“ at the University of Bonn, which promote interdisciplinary research on the immune system. It also highlights the close international and national collaboration with researchers in Wuhan (China), at the University Medical Center Hamburg-Eppendorf, and at LMU Munich.

"MERLIN opens up a new dimension in single-cell research," summarizes Junping Yin. "We can re-evaluate existing data sets and gain a much more precise understanding of disease mechanisms."

Funding

In addition to funding from the ImmunoSensation³ Cluster of Excellence at the University of Bonn, the study was supported by the German Research Foundation (DFG) within the framework of TRR 237 Nucleic Acid Immunity and FOR 5427 Bacterial Renal Infections and Their Defense, and SFB 1192: Immune-Mediated Glomerular Diseases.

Publication

Junping Yin et al.: Predicting Macrophage Spatial Localization from Single-Cell Transcriptomes to Uncover Disease Mechanisms; Advanced Science; DOI: 10.1002/advs.202410924

Contact

Prof. Dr. Christian Kurts
Institute for Molecular Medicine and Experimental Immunology
University Hospital Bonn
ImmunoSensation3 and TRA & Life and Health Clusters of Excellence, University of Bonn
Email: ckurts@uni-bonn.de

Related news

Bunte Spirale

News categories: Publication

When the map needs an update

Every time we move through a familiar environment, the hippocampus consults an internal map, a detailed spatial representation that is built up through repeated experience. But what happens when something unexpected occurs on a well-known route? Researchers at the UKB and the University of Bonn were able to demonstrate in a mouse model that the brain does not redraw its maps from scratch. Instead, it annotates them: preserving the underlying spatial layout while overlaying new information on top of the existing map. Their findings have now been published in the journal PNAS.
View entry
Dr. Clivia Lisowski und Prof. Christian Kurts

News categories: Publication

Immune cells in the liver help pigeons navigate

How do pigeons find their way home safely over distances of many kilometers? A research team from the University Hospital Bonn (UKB), the University of Bonn, the University of Duisburg-Essen, and the Max Planck Institute for Behavioral Biology has now discovered a previously unknown mechanism: specific immune cells in the liver may help the birds detect the Earth’s magnetic field. The findings have now been published in the journal Science.
View entry
News Icon

News categories: Publication

Twin Lancet Publications Highlight Promising New Approach for Lupus Treatment

A team of international researchers, including ImmunoSensation³ member Prof. Jörg Wenzel, reports promising phase 2 results for enpatoran, a first-in-class oral TLR7/8 inhibitor, in patients with cutaneous and systemic lupus erythematosus (CLE/SLE). In the WILLOW trial, enpatoran significantly improved skin disease activity in a dose-dependent manner and showed favourable safety outcomes. In systemic SLE, treatment also reduced global disease activity and rapidly suppressed the type I interferon gene signature. The twin studies were published in The Lancet and The Lancet Rheumatology.
View entry

Back to the news overview